http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102033187-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate | 2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102033187-B1 |
| titleOfInvention | Tablet containing dehydroepiandrosterone (dhea) |
| abstract | The present invention relates to a tablet having a weight of 30 to 200 mg, consisting of: a) 60 to 100% by weight of granules; 50-90% by weight of dihydroepiandrosterone (DHEA) in the granules; 6 to 35% by weight of microcrystalline cellulose in the granules; 0 to 20% by weight of the granules of at least one pharmaceutically acceptable other granule component; And b) 0 to 40% by weight of one or more other pharmaceutically acceptable tablet components. Such tablets may suitably be used for oral administration of DHEA at a dosage of about 50 mg, and are small enough to be included, for example, in ordinary oral contraceptive blister packs. |
| priorityDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.